Apium
Develops industrial FFF 3D printers and high-performance polymer filaments for demanding applications like medical implants and aerospace components.
- CEO / Founder
- Lars Pfotzer
- Team Size
- 11-50
- Stage
- Active
- Latest Round
- Acquisition
Technology & Products
Key Products
Apium P220 3D printer; Apium P400 3D printer; Apium M220 3D printer; High-performance polymer filaments (PEEK, PP, etc.); Apium Filament Dryer
Technological Advantage
Proprietary FFF process and filament formulations optimized for high-temperature polymers like PEEK, enabling industrial-grade part production. Technology focus on medical and aerospace applications provides vertical specialization. However, the core FFF process is widely available, and the advantage may be in material-process integration rather than an unassailable technical moat.
Differentiation
Value Proposition
Enables affordable, patient-specific medical implants and high-strength industrial components using proprietary FFF technology optimized for engineering-grade thermoplastics like PEEK, reducing reliance on traditional manufacturing.
How They Differentiate
Focuses specifically on high-performance thermoplastics (PEEK, PP) within the industrial FFF segment, unlike broader polymer AM players. Apium's P400 platform is positioned for multi-material/multi-tool flexibility. However, competes directly with Intamsys (FUNMAT series) and high-end systems from 3D Systems and Stratasys on material capability and build volume.
Market & Competition
Target Customers
Industrial manufacturers, medical device companies, and aerospace/defense contractors requiring high-performance polymer parts.
Industry Verticals
Medical; Aerospace/Defense; Industrial Manufacturing
Competitors
Intamsys; 3D Systems (with high-temperature FFF systems); Stratasys (FDM/FFF for engineering materials)
Growth & Milestones
Growth Metrics
Reported annual sales of around one million euros (approx. $1.1M USD) as of 2023/2024, with 15 employees at that time. Company has faced financial distress, entering insolvency proceedings in 2024 while seeking new investment.
Major Milestones
Founded (2016); Reported reaching ~€1M annual sales (2023); Entered insolvency proceedings (2024)